A. Gilbert

发表

Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT

A. Scarsbrook, S. Currie, D. Sebag‐Montefiore, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Recommendations for including or reviewing patient reported outcome endpoints in grant applications

D. Moher, C. Snyder, M. Brundage, 2021, BMJ.

Functional Outcomes and Health-Related Quality of Life After Curative Treatment for Rectal Cancer: A Population-Level Study in England.

P. Wright, A. Glaser, D. Sebag‐Montefiore, 2019, International journal of radiation oncology, biology, physics.

Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study

A. Darzi, R. Peto, P. Ziprin, 2020, The lancet. Gastroenterology & hepatology.

Delayed response assessment with FDG-PET-CT following (chemo) radiotherapy for locally advanced head and neck squamous cell carcinoma.

A. Scarsbrook, F. Chowdhury, M. Subesinghe, 2012, Clinical radiology.

The benefit of MR‐only radiotherapy treatment planning for anal and rectal cancers: A planning study

D. Buckley, A. Henry, M. Teo, 2021, Journal of applied clinical medical physics.

A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial

S. Bach, M. Teo, D. Sebag‐Montefiore, 2022, BMJ Open.

Phase I-III development of the EORTC QLQ-ANL27, a health-related quality of life questionnaire for anal cancer.

Hans T. Chung, K. Tomaszewski, V. Vassiliou, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of patient-reported outcomes to measure symptoms and health related quality of life in the clinic.

G. Velikova, D. Sebag‐Montefiore, S. Davidson, 2015, Gynecologic oncology.

Multicentre, deep learning, synthetic-CT generation for ano-rectal MR-only radiotherapy treatment planning

D. Buckley, A. Henry, M. Teo, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study

M. Eble, A. Dekker, D. Thwaites, 2022, Diagnostic and Prognostic Research.

Assessing the patient experience of anal and rectal cancer MR simulation for radiotherapy treatment planning

A. Henry, M. Teo, D. Sebag‐Montefiore, 2021, Journal of Radiotherapy in Practice.

Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy

A. Scarsbrook, A. Gilbert, N. Casanova, 2022, European Radiology.

UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes.

R. Muirhead, R. Glynne-Jones, D. Sebag‐Montefiore, 2020, European journal of cancer.

Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review

A. Henry, D. Sebag‐Montefiore, A. Gilbert, 2022, BMC cancer.

Patient position verification in magnetic-resonance imaging only radiotherapy of anal and rectal cancers

D. Buckley, A. Henry, D. Sebag‐Montefiore, 2021, Physics and imaging in radiation oncology.

Long-term swallow function after chemoradiotherapy for oropharyngeal cancer: the influence of a prophylactic gastrostomy or reactive nasogastric tube.

M. Teo, A. Gilbert, R. Prestwich, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Quality-of-life outcomes in older patients with early-stage rectal cancer receiving organ-preserving treatment with hypofractionated short-course radiotherapy followed by transanal endoscopic microsurgery (TREC): non-randomised registry of patients unsuitable for total mesorectal excision

A. Darzi, R. Peto, P. Ziprin, 2022, The Lancet. Healthy longevity.

Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making.

P. Fayers, J. Kieffer, J. Blazeby, 2014, European journal of cancer.

CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer

C. Hiley, A. Ryan, C. Faivre-Finn, 2020, Clinical and translational radiation oncology.

Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy

K. Tomaszewski, V. Vassiliou, R. Glynne-Jones, 2015, Supportive Care in Cancer.

Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting.

G. Velikova, D. Sebag‐Montefiore, F. Efficace, 2015, International journal of radiation oncology, biology, physics.

Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - a proof-of-concept study.

A. Dekker, J. van Soest, M. Berbée, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

K. Haustermans, G. Beets, C. Marijnen, 2021, Nature Reviews Clinical Oncology.

Time to Surgery Following Short-Course Radiotherapy in Rectal Cancer and its Impact on Postoperative Outcomes. A Population-Based Study Across the English National Health Service, 2009–2014

D. Sebag‐Montefiore, E. Morris, John C. Taylor, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020

R. Muirhead, M. Teo, D. Sebag‐Montefiore, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Anal Cancer: Putting Health-Related Quality of Life at the Forefront.

V. Vassiliou, A. Darlington, A. Gilbert, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

DPD testing in radical chemoradiation for anal squamous cell carcinoma.

R. Muirhead, A. Gilbert, D. Gilbert, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Radical surgery versus organ preservation for early-stage rectal cancer - Authors' reply.

S. Bach, D. Sebag‐Montefiore, A. Gilbert, 2021, The lancet. Gastroenterology & hepatology.

Linking the European Organisation for Research and Treatment of Cancer Item Library to the Common Terminology Criteria for Adverse Events

M. Groenvold, A. Bottomley, J. Blazeby, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy

K. Franks, A. Henry, G. Velikova, 2018, Pilot and Feasibility Studies.

OC-0416: eRAPID: Electronic self-report and management of adverse-events for radical prostate radiotherapy (RT) patients

K. Franks, A. Henry, G. Velikova, 2015 .

PO-1303: Radiotherapy platform trials: accelerating our ability to answer important scientific questions

D. Sebag‐Montefiore, A. Gilbert, S. Brown, 2020 .

FOxTROT2: innovative trial design to evaluate the role of neoadjuvant chemotherapy for treating locally advanced colon cancer in older adults or those with frailty

D. Cairns, J. Taieb, A. Gilbert, 2022, ESMO open.

Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.

K. Franks, A. Henry, G. Velikova, 2017, International journal of radiation oncology, biology, physics.

Listening to the Patient Voice Adds Value to Cancer Clinical Trials

D. Moher, C. Snyder, Samantha Cruz Rivera, 2022, Journal of the National Cancer Institute.

Deep learning with visual explanation for radiotherapy-induced toxicity prediction

Alejandro F Frangi, A. Scarsbrook, A. Gooya, 2023, Medical Imaging.

Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.

K. Franks, A. Henry, G. Velikova, 2017, International journal of radiation oncology, biology, physics.

Choice of a patient-reported outcome measure for patients with anal cancer for use in cancer clinical trials and routine clinical practice: a mixed methods approach

J. Blazeby, G. Velikova, D. Sebag‐Montefiore, 2015, The Lancet.

Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research

A. Coulter, T. Wykes, R. Fitzpatrick, 2016, Health and Quality of Life Outcomes.

P. Wright, A. Glaser, D. Sebag‐Montefiore, 2016 .

Radiotherapy side effects and their management

A. Gilbert, R. Prestwich, E. Dugdale, 2014 .

Introduction to radiotherapy

A. Gilbert, R. Prestwich, E. Dugdale, 2014 .